State FL
Clinical Trials in Florida
Recruiting clinical trials with at least one study location in Florida. Data updated daily from ClinicalTrials.gov.
Top Conditions in Florida
NCT07217834 N/A
Recruiting
Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrate...
Condition
Fluid Balance
Enrollment
30 pts
Location
United States
Sponsor
PepsiCo Global R&D
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT05462704 Phase 3
Recruiting
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Condition
Iron Deficiency Anemia
Enrollment
300 pts
Location
United States
Sponsor
Women and Infants Hospital of
NCT04929028 Phase 2
Recruiting
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Condition
AIDS-Related Anal Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07116876 N/A
Recruiting
Matrion Decellularized Placental Membrane Versus Conventional Wound Management i...
Condition
Diabetic Foot Ulcer (DFU)
Enrollment
120 pts
Location
United States
Sponsor
LifeNet Health
NCT04064060 Phase 3
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Ot...
Condition
Myelodysplastic Syndromes (MDS)
Enrollment
665 pts
Location
United States, Australia, Belgium
Sponsor
Celgene
NCT06684470 EARLY_Phase 1
Recruiting
Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Thera...
Condition
IBS - Irritable Bowel Syndrome
Enrollment
20 pts
Location
United States
Sponsor
Mayo Clinic
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT07197866 Phase 2
Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple Syste...
Condition
Multiple System Atrophy
Enrollment
200 pts
Location
United States, Germany, Israel
Sponsor
Teva Branded Pharmaceutical Pr
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sl...
Condition
Obesity
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT04322370 N/A
Recruiting
Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Fl...
Condition
Flexor Tendon
Enrollment
42 pts
Location
United States
Sponsor
University of Florida
NCT06990269 Phase 2
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
ADARx Pharmaceuticals, Inc.
NCT05857969 Phase 1
Recruiting
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Condition
Recurrent Childhood Acute Myeloid Leukemia
Enrollment
65 pts
Location
United States
Sponsor
Florida International Universi
NCT05504837 Phase 1
Recruiting
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Condition
Cystic Fibrosis
Enrollment
12 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
NCT05847569 Phase 2
Recruiting
Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Tr...
Condition
Recurrent Multiple Myeloma
Enrollment
62 pts
Location
United States
Sponsor
Mayo Clinic
NCT06932341 N/A
Recruiting
Leveraging Electronic Health Record Tools to Improve the Evidence-Based Treatmen...
Condition
Bronchiolitis
Enrollment
800 pts
Location
United States
Sponsor
Johns Hopkins University
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05301283 Phase 2
Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft T...
Condition
High Grade Sarcoma
Enrollment
43 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT06071845 N/A
Recruiting
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of E...
Condition
Barrett Esophagus
Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
NCT07216872 N/A
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation...
Condition
Alcohol Use Disorder
Enrollment
186 pts
Location
United States, Israel
Sponsor
Brainsway